Literature DB >> 11343869

Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia.

H V Nikkilä1, K Müller, A Ahokas, R Rimón, L C Andersson.   

Abstract

We compared the cerebrospinal fluid (CSF) cytology of 30 acutely psychotic patients at the initial phase of their hospital treatment with that of 46 control individuals with no psychiatric disorder or central nervous system (CNS) disease. The cytological profile of May-Grünwald-Giemsa stained CSF cell slides of the patients was significantly different from that of the control population. The most striking finding was a significantly increased frequency of lymphoid cells showing morphological features of activation/stimulation and a decreased proportion of normal small lymphocytes. Many of the cells with aberrant morphology displayed structural details similar to those of the 'P cells' previously described in the blood of schizophrenic patients. The patients' CSF also contained elevated proportions of monocytes/macrophages, some of which were found in 'rosettes' with activated lymphocytes indicating an increased intercellular adhesion. Possible pathogenic mechanisms behind lymphocyte activation and macrophage dominance in the CSF of acutely ill psychotic patients are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11343869     DOI: 10.1016/s0920-9964(99)00218-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

2.  Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia.

Authors:  Hui-Min Fan; Xin-Yang Sun; Wei Niu; Lin Zhao; Qiao-Li Zhang; Wan-Shuai Li; Ai-Fang Zhong; Li-Yi Zhang; Jim Lu
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

Review 3.  Inflammation and schizophrenia.

Authors:  Brian Kirkpatrick; Brian J Miller
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

Review 4.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

Review 5.  Is it time for immunopsychiatry in psychotic disorders?

Authors:  Marion Leboyer; José Oliveira; Ryad Tamouza; Laurent Groc
Journal:  Psychopharmacology (Berl)       Date:  2016-03-18       Impact factor: 4.530

6.  A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.

Authors:  Ellen Kure Fischer; Antonio Drago
Journal:  J Neural Transm (Vienna)       Date:  2017-05-05       Impact factor: 3.575

Review 7.  Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.

Authors:  Monojit Debnath
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-11       Impact factor: 4.147

8.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

Review 9.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

Review 10.  Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.

Authors:  Golam M Khandaker; Lesley Cousins; Julia Deakin; Belinda R Lennox; Robert Yolken; Peter B Jones
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.